Ftse Mib
34.094,90
1,05%
DAX
19.958,63
0,61%
S&P 500
5.957,00
-1,33%
NASDAQ
19.688,96
-1,66%
Bitcoin
94.344,16
-1,41%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG Pharming Group NV (PHGN) Pharming Group NV (PHGN) Notizie

Pharming Group NV

PHGN
0,942
0,049 (5,49%)
17:49:04 - Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
15/12/202419:45UKREGPharming announces public cash offer to the shareholders of..
11/12/202407:00UKREGPharming announces positive topline data in pediatric..
24/10/202407:00UKREGPharming Group reports third quarter 2024 financial results..
10/10/202408:00UKREGPharming Group to report third quarter 2024 financial..
10/10/202407:00UKREGPharming Group announces start of Phase II clinical trial of..
26/9/202407:00UKREGPharming announces marketing authorization in the U.K. for..
01/8/202407:00UKREGPharming Group reports second quarter and first half 2024..
18/7/202408:00UKREGPharming Group to report second quarter and first half 2024..
03/6/202408:00GLOBEPharming Group to participate in June investor conferences
30/5/202422:44GLOBEPharming Group provides update on ongoing regulatory review..
21/5/202417:30GLOBEPharming Group reports on results of the 2024 Annual General..
20/5/202408:00GLOBEPharming Group to participate in May investor conference
15/5/202407:00GLOBEPharming Group announces the early redemption of the..
08/5/202407:00GLOBEPharming Group reports first quarter 2024 financial results..
24/4/202408:00GLOBEPharming Group to report first quarter 2024 financial..
24/4/202407:00GLOBEPharming to be honored as Industry Innovator at National ..
19/4/202418:43GLOBEPharming Group announces the repurchase of outstanding €125..
18/4/202415:04GLOBEPharming Group announces the placement of €100 million..
18/4/202408:00GLOBEPharming Group announces the launch of an offering of..
08/4/202407:00GLOBEPharming announces completion of enrollment in pediatric..
04/4/202408:30GLOBEPharming Group announces the 2024 Annual General Meeting of..
04/4/202407:00GLOBEPharming Group announces the filing of its 2023 Annual..
03/4/202408:00GLOBEPharming Group to participate in April investor conferences
14/3/202407:00GLOBEPharming Group reports fourth quarter and full year 2023..
29/2/202408:00GLOBEPharming Group to report fourth quarter and full year 2023..
08/2/202408:00GLOBEPharming Group to participate in February investor..
08/1/202407:00GLOBEPharming Group announces updated full year 2023 guidance and..
Apertura: 0,8945 Min: 0,889 Max: 0,9495
Chiusura: 0,893

La tua Cronologia

TG
PHGN
Pharming Group NV
ASX
XNT
S&P ASX 200 Net Total Re...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network